Month: February 2022

91895-29-3, 6,7-Difluoroquinoxaline-2,3(1H,4H)-dione is a quinoxaline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

Example 88 Preparation of 6,7-Difluoro-5-nitro-1,4-dihydro-2,3-quinoxalinedione To a suspension of 6,7-difluoro-1,4-dihydro-2,3-quinoxalinedione (837 mg, 4.23 mmol) in trifluoracetic acid (30 mL) was added KNO3 (512 mg, 5.07 mmol). The mixture was stirred at 55 C. for 20 h at the end of this time, 256 mg (2.50 mmol) of KNO3 was added and the reaction mixture was stirred at 55 C. for 20 h, then another 256 mg (2.50 mmol) of KNO3 was added and the mixture was stirred at 55 C. for 20 h. The reaction mixture was then rota-evaporated to dryness. To the residual solid was added ice-cold water (about 15 mL), the solid was collected by vacuum filtration, washed with ice-cold water (5*5 mL), and dried at 40 C. under 1 mm Hg for 14 h, giving 700 mg (68%) of the title compound as a yellow powder. Mp 288-90 C. (dec.). IR (KBr) 3424, 3226, 1752, 1717, 1554, 1356, 1304 cm-1. 1 H NMR (DMSO-d6): 12.249 (s, 1H), 11.864 (bs, 1H), 7.330 (dd, 1H, J=10.5, 7.8 Hz). Analysis for C8 H3 F2 N3 O4, calcd: C, 39.50, H, 1.24, N, 17.29; found: C, 39.42, H, 1.26, N, 17.08., 91895-29-3

91895-29-3 6,7-Difluoroquinoxaline-2,3(1H,4H)-dione 822839, aquinoxaline compound, is more and more widely used in various fields.

Reference：
Patent; The State of Oregon, acting by and through The Oregon State Board of Higher Education, acting for and on behalf of The Oregon Health Sciences University; The University of Oregon; The Regents of the University of California; US5514680; (1996); A;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

62163-09-1, 5-Chloroquinoxaline is a quinoxaline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated,62163-09-1

EXAMPLE IV 5-(1-piperazinyl)quinoxalin, hydrochloride. 0.2 Mol (33.5 g) of 5-chloroquinoxalin and 2.1 mol (184 g) of piperazine were mixed in 180 ml of ethylene glycol and refluxed for 20 hours. The reaction mixture was poured on ice and acidified with concentrated hydrochloric acid and then extracted with 3*200 ml of ether. The water layer was made alkaline while cooling with ice, with 50% sodium hydroxide and then extracted with 3*600 ml of methylene chloride. The combined methylene chloride solution was washed successively with 1 l of 1N sodium hydroxide and a mixture of 925 ml of a saturated saline solution and 75 ml of 50% potassium hydroxide. The organic solution was dried on sodium sulphate and was then evaporated to dryness in vacuo. The residue was chromatographed over silica gel with a mixture of methylene chloride, methanol, and 25% ammonia (92:7.5:0.5) as eluent. The resulting free base was dissolved in ethanol and 1 equivalent of hydrochloric acid in ethanol was added. The title compound was obtained with a melting-point of 271-272 C.

The synthetic route of 62163-09-1 has been constantly updated, and we look forward to future research findings.

Reference：
Patent; Duphar International Research B.V.; US5424313; (1995); A;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

91895-29-3, 6,7-Difluoroquinoxaline-2,3(1H,4H)-dione is a quinoxaline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

Example 88 Preparation of 6,7-Difluoro-5-nitro-1,4-dihydro-2,3-quinoxalinedione To a suspension of 6,7-difluoro-1,4-dihydro-2,3-quinoxalinedione (837 mg, 4.23 mmol) in trifluoracetic acid (30 mL) was added KNO3 (512 mg, 5.07 mmol). The mixture was stirred at 55 C. for 20 h at the end of this time, 256 mg (2.50 mmol) of KNO3 was added and the reaction mixture was stirred at 55 C. for 20 h, then another 256 mg (2.50 mmol) of KNO3 was added and the mixture was stirred at 55 C. for 20 h. The reaction mixture was then rota-evaporated to dryness. To the residual solid was added ice-cold water (about 15 mL), the solid was collected by vacuum filtration, washed with ice-cold water (5*5 mL), and dried at 40 C. under 1 mm Hg for 14 h, giving 700 mg (68%) of the title compound as a yellow powder. Mp 288-90 C. (dec.). IR (KBr) 3424, 3226, 1752, 1717, 1554, 1356, 1304 cm-1. 1 H NMR (DMSO-d6): 12.249 (s, 1H), 11.864 (bs, 1H), 7.330 (dd, 1H, J=10.5, 7.8 Hz). Analysis for C8 H3 F2 N3 O4, calcd: C, 39.50, H, 1.24, N, 17.29; found: C, 39.42, H, 1.26, N, 17.08., 91895-29-3

91895-29-3 6,7-Difluoroquinoxaline-2,3(1H,4H)-dione 822839, aquinoxaline compound, is more and more widely used in various fields.

Reference：
Patent; The State of Oregon, acting by and through The Oregon State Board of Higher Education, acting for and on behalf of The Oregon Health Sciences University; The University of Oregon; The Regents of the University of California; US5514680; (1996); A;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

62163-09-1, 5-Chloroquinoxaline is a quinoxaline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated,62163-09-1

EXAMPLE IV 5-(1-piperazinyl)quinoxalin, hydrochloride. 0.2 Mol (33.5 g) of 5-chloroquinoxalin and 2.1 mol (184 g) of piperazine were mixed in 180 ml of ethylene glycol and refluxed for 20 hours. The reaction mixture was poured on ice and acidified with concentrated hydrochloric acid and then extracted with 3*200 ml of ether. The water layer was made alkaline while cooling with ice, with 50% sodium hydroxide and then extracted with 3*600 ml of methylene chloride. The combined methylene chloride solution was washed successively with 1 l of 1N sodium hydroxide and a mixture of 925 ml of a saturated saline solution and 75 ml of 50% potassium hydroxide. The organic solution was dried on sodium sulphate and was then evaporated to dryness in vacuo. The residue was chromatographed over silica gel with a mixture of methylene chloride, methanol, and 25% ammonia (92:7.5:0.5) as eluent. The resulting free base was dissolved in ethanol and 1 equivalent of hydrochloric acid in ethanol was added. The title compound was obtained with a melting-point of 271-272 C.

The synthetic route of 62163-09-1 has been constantly updated, and we look forward to future research findings.

Reference：
Patent; Duphar International Research B.V.; US5424313; (1995); A;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider